Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma

Detalles Bibliográficos
Autores principales: Wang, Xuan, Xiong, Zhiyong, Liu, Zhen, Huang, Xing, Jiang, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414596/
https://www.ncbi.nlm.nih.gov/pubmed/30862806
http://dx.doi.org/10.1038/s41598-019-40291-5
_version_ 1783403003043119104
author Wang, Xuan
Xiong, Zhiyong
Liu, Zhen
Huang, Xing
Jiang, Xiaobing
author_facet Wang, Xuan
Xiong, Zhiyong
Liu, Zhen
Huang, Xing
Jiang, Xiaobing
author_sort Wang, Xuan
collection PubMed
description
format Online
Article
Text
id pubmed-6414596
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64145962019-03-14 Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma Wang, Xuan Xiong, Zhiyong Liu, Zhen Huang, Xing Jiang, Xiaobing Sci Rep Author Correction Nature Publishing Group UK 2019-03-12 /pmc/articles/PMC6414596/ /pubmed/30862806 http://dx.doi.org/10.1038/s41598-019-40291-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Wang, Xuan
Xiong, Zhiyong
Liu, Zhen
Huang, Xing
Jiang, Xiaobing
Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
title Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
title_full Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
title_fullStr Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
title_full_unstemmed Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
title_short Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
title_sort author correction: angiopep-2/ip10-egfrviiiscfv modified nanoparticles and ctl synergistically inhibit malignant glioblastoma
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414596/
https://www.ncbi.nlm.nih.gov/pubmed/30862806
http://dx.doi.org/10.1038/s41598-019-40291-5
work_keys_str_mv AT wangxuan authorcorrectionangiopep2ip10egfrviiiscfvmodifiednanoparticlesandctlsynergisticallyinhibitmalignantglioblastoma
AT xiongzhiyong authorcorrectionangiopep2ip10egfrviiiscfvmodifiednanoparticlesandctlsynergisticallyinhibitmalignantglioblastoma
AT liuzhen authorcorrectionangiopep2ip10egfrviiiscfvmodifiednanoparticlesandctlsynergisticallyinhibitmalignantglioblastoma
AT huangxing authorcorrectionangiopep2ip10egfrviiiscfvmodifiednanoparticlesandctlsynergisticallyinhibitmalignantglioblastoma
AT jiangxiaobing authorcorrectionangiopep2ip10egfrviiiscfvmodifiednanoparticlesandctlsynergisticallyinhibitmalignantglioblastoma

Ejemplares similares